Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Expert Review of Hematology
|
February 5, 2013
Assessing response of therapy for acute and chronic graft-versus-host disease
Jenna D Goldberg, Sergio Giralt
Transplantation
|
August 31, 2010
Rapid engraftment at a cost?
Jenna D Goldberg, Georgia B Vogelsang
The New England Journal of Medicine
|
November 2, 2022
Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply
Philippe Moreau, Suzette Girgis, Jenna D Goldberg
Journal of Pediatric Hematology/Oncology
|
July 9, 2003
Pentostatin for the treatment of chronic graft-versus-host disease in children
Jenna D Goldberg, David A Jacobsohn, Jeffrey Margolis, et al.
Journal of Cellular and Molecular Medicine
|
November 21, 2013
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
Saroj Vadhan-Raj, Jenna D Goldberg, Miguel-Angel Perales, et al.
Cancer Reports (Hoboken, N.J.)
|
February 15, 2022
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies
Rebecca Crawford, Katharine S Gries, Satish Valluri, et al.
Leukemia & Lymphoma
|
June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant
Izaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
British Journal of Haematology
|
August 24, 2017
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies
Simon Rule, Martin Dreyling, Andre Goy, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 4, 2024
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab
Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, et al.
Blood Advances
|
August 25, 2022
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Expert Review of Hematology
|
February 5, 2013
Assessing response of therapy for acute and chronic graft-versus-host disease
Jenna D Goldberg, Sergio Giralt
Transplantation
|
August 31, 2010
Rapid engraftment at a cost?
Jenna D Goldberg, Georgia B Vogelsang
The New England Journal of Medicine
|
November 2, 2022
Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply
Philippe Moreau, Suzette Girgis, Jenna D Goldberg
Journal of Pediatric Hematology/Oncology
|
July 9, 2003
Pentostatin for the treatment of chronic graft-versus-host disease in children
Jenna D Goldberg, David A Jacobsohn, Jeffrey Margolis, et al.
Journal of Cellular and Molecular Medicine
|
November 21, 2013
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
Saroj Vadhan-Raj, Jenna D Goldberg, Miguel-Angel Perales, et al.
Cancer Reports (Hoboken, N.J.)
|
February 15, 2022
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies
Rebecca Crawford, Katharine S Gries, Satish Valluri, et al.
Leukemia & Lymphoma
|
June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant
Izaskun Ceberio, Sean M Devlin, Craig Sauter, et al.
British Journal of Haematology
|
August 24, 2017
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies
Simon Rule, Martin Dreyling, Andre Goy, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 4, 2024
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab
Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, et al.
Blood Advances
|
August 25, 2022
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti, et al.
Page
of 4